Clinical trial phase that monitors the effectiveness and side effects of the drug

Clinical trial phase that monitors the effectiveness and side effects of the drug

• A. Phase III
• B. Phase II
• C. Phase I
• D. Phase IV

Answer: (C)

Assessing whether a drug works and what side effects it has happens in the phase that follows the initial safety studies. After safety and dosing are explored in early testing, this middle stage enrolls patients who actually have the condition to see if the drug demonstrates meaningful effectiveness while continuing to monitor adverse effects and determine the best dosing. This phase provides the first concrete signals of benefit and safety in the target population, which helps decide whether to advance to larger, more definitive testing. In contrast, the initial phase focuses on safety and pharmacokinetics, and the later phase expands monitoring in a larger population to confirm efficacy and compare to standard treatments, while the post-marketing phase tracks long-term safety.

Assessing whether a drug works and what side effects it has happens in the phase that follows the initial safety studies. After safety and dosing are explored in early testing, this middle stage enrolls patients who actually have the condition to see if the drug demonstrates meaningful effectiveness while continuing to monitor adverse effects and determine the best dosing. This phase provides the first concrete signals of benefit and safety in the target population, which helps decide whether to advance to larger, more definitive testing. In contrast, the initial phase focuses on safety and pharmacokinetics, and the later phase expands monitoring in a larger population to confirm efficacy and compare to standard treatments, while the post-marketing phase tracks long-term safety.